BlackRock Group’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$12.6M Buy
460,568
+48,499
+12% +$1.33M 0.01% 878
2016
Q3
$25.3M Buy
412,069
+334,842
+434% +$20.6M 0.01% 735
2016
Q2
$1.47M Buy
77,227
+53,332
+223% +$1.02M ﹤0.01% 1738
2016
Q1
$467K Buy
23,895
+5,404
+29% +$106K ﹤0.01% 2256
2015
Q4
$713K Sell
18,491
-98,761
-84% -$3.81M ﹤0.01% 2047
2015
Q3
$3.77M Buy
117,252
+105,084
+864% +$3.38M ﹤0.01% 1193
2015
Q2
$371K Buy
12,168
+2,225
+22% +$67.8K ﹤0.01% 2355
2015
Q1
$132K Buy
9,943
+1,812
+22% +$24.1K ﹤0.01% 2588
2014
Q4
$118K Buy
8,131
+3,106
+62% +$45.1K ﹤0.01% 2631
2014
Q3
$106K Sell
5,025
-1,013
-17% -$21.4K ﹤0.01% 2560
2014
Q2
$180K Sell
6,038
-14,812
-71% -$442K ﹤0.01% 2456
2014
Q1
$501K Buy
20,850
+3,995
+24% +$96K ﹤0.01% 2210
2013
Q4
$344K Buy
16,855
+3,235
+24% +$66K ﹤0.01% 2288
2013
Q3
$643K Buy
13,620
+908
+7% +$42.9K ﹤0.01% 2112
2013
Q2
$484K Buy
+12,712
New +$484K ﹤0.01% 2048